SS Innovations International Announces Q1 2024 Company Updates

Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system

FORT LAUDERDALE, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced its Q1 2024 Company updates.

As of March 31, 2024, SS Innovations has completed a total of 32 successful installations of the SSi Mantra Surgical Robotic System in medical facilities across India. In addition, four cardiac surgery programs have been launched utilizing the SSi Mantra for the full spectrum of robotic cardiac surgeries. For the quarter ended March 31, 2024, SS Innovations sold 8 SSi Mantra Surgical Robotic Systems and expects to report revenues of approximately US $7 million, which exceeds revenues reported for the entire year ended December 31, 2023. Of the 8 robotic systems sold in the first quarter of 2024, 3 were sold to large medical colleges in India, which also operate teaching hospitals. In addition, SS Innovations also installed a robotic system at the World Laparoscopy Hospital, which is a prominent Minimal Access Surgery Training Institute in India.

SS Innovations Founder and Chairman, Dr. Sudhir Srivastava, said, “We are very excited to announce that training on our Made-in-India SSi Mantra surgical robotic system is now being conducted at the World Laparoscopy Hospital in Gurugram, India. We believe that this affords the Company a highly visible platform to introduce the more than 1,000 doctors from all over the world, who visit this training institute annually, to our advanced surgical robotic system, the SSI Mantra, thereby potentially increasing adoption of our system in their respective countries.”

SS Innovations also announced that its flagship SSi Mantra Surgical Robotic System has successfully completed 1,000 surgeries, a significant milestone for the company. The SSI Mantra Surgical Robotic System has now been utilized in more than 60 different surgical procedures, including cardiothoracic, head and neck, gynecology, urology, and general surgeries in India.

SS Innovations Founder and Chairman, Dr. Sudhir Srivastava, further stated, “We are very excited to announce that our Made-in-India SSi Mantra Surgical Robotic System has now been used in more than 1,000 surgeries. This important milestone would not have been possible without the unwavering support of surgeons in India and around the world. “